Stem Cells from Skin Fibroblasts in Patients with Hereditary Peripheral Neuropathy


About this study

The purpose of this research is to develop stem cells from cells within patients’ skin in order to better understand peripheral neuropathy and help develop treatments.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients with clinically documented peripheral neuropathy as determined by a Mayo Clinic Neurologist.
  • Adult patients with either a known genetic mutation causative for the peripheral neuropathy or a documented family history of peripheral neuropathy.
  • Adult biological family members of affected patient.

Exclusion Criteria:

  • Adult patients with peripheral neuropathy caused by other etiologies in the estimation of the Mayo Clinic Neurologist without a hereditary component.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nathan Staff, M.D., Ph.D.

Open for enrollment

Contact information:

Michelle Turner

(507) 284-1223

More information


Publications are currently not available

Mayo Clinic Footer